9.33 -0.14 (-1.48%)

25.40% Gain from 52W Low

21,014 XNAS Volume

XNAS 20 Mar, 2025 12:45 PM (EDT)

Theravance Biopharma Inc - TBPH - stock price prediction, stock price target, analyst ratings from 4 analysts

Theravance Biopharma Inc has a share price target of US$ 14, revenue growth forecast of 60.4%, and profit growth estimate of 84.6% for FY25, based on top 4 analyst calls.